“Tearing Down the Walls” to Clinical Trial Access

This design, submitted by CureLauncher, reflects our dedication to creating a patient-centric approach to clinical trials. Our goal is to empower patients by having their best interest in mind. During the person’s first experience, they express a sense of relief that they’ve started a journey, with clear steps toward health outcomes. We’ve already achieved this experience with patients and are tearing down the walls that have hindered patient access to clinical trials.

A patient-centric approach, with easy-to-understand information, creates clear and measurable improvements to clinical research. It delivers better qualified participants who are motivated to enroll when they understand the risks and benefits. In using this approach, 50% of the volunteers referred to trial sites have been enrolled [CureLauncher metrics].